The market for cancer drugs in China grew 22% in 2007, totaling 25.5 billion RMB ($3.6 billion). In 2006, the total outlay for cancer drugs increased by “only” 11%, in part because of a government crackdown on bribery in the supply chain. The compound annual growth rate for cancer drugs in 2003-5 was also 22%. Cancer was the leading cause of death in both urban and rural areas. More details...